Literature DB >> 21679507

Bacterial interference in upper respiratory tract infections: a systematic review.

Michael Benninger1, Itzhak Brook, Joel M Bernstein, Janet R Casey, Kristian Roos, Bradley Marple, Judith R Farrar.   

Abstract

BACKGROUND: Published definitions of bacterial interference (BI) differ, some focusing on changes in the normal flora and others on changes in subsequent infection. A need for consensus was identified at a roundtable discussion of BI in upper respiratory tract infections (URTI). We conducted a systematic review of the available data to justify a consensus definition of BI specific to URTI as "a dynamic, antagonistic interaction between at least 2 organisms that affects the life cycle of each, changes the microenvironment, and alters the organisms' colonization, invasiveness, and ability to affect the health of the host."
METHODS: Continued communication among the faculty postroundtable was used to identify and refine the search criteria to (1) in vitro and in vivo studies assessing bacterial URTI, (2) BI evaluated by response to treatment of URTI with antimicrobial agents, and (3) bacterial function in relation to interactions between normal (nonpathogenic) and pathological flora. The criteria were applied to systematic searches of MEDLINE (1950 onward), EMBASE (1974 onward), and the Cochrane Library (2007).
RESULTS: Twenty-nine studies met the inclusion criteria, most focused on children with recurrent infections. Qualitative analysis supports the consensus definition. Interfering organisms affected the life cycle of test pathogens and inhibited their colonization, invasiveness, and health outcomes. Data were insufficient for statistical analysis.
CONCLUSION: Interactions between interfering organisms and potential pathogens isolated from the same host can alter response to infection and treatment. More studies are needed, particularly in adults, to understand the role of interfering organisms, the influence of antibiotics, and the potential for recolonization posttreatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679507     DOI: 10.2500/ajra.2011.25.3594

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  4 in total

1.  Effect of SARS-CoV-2 Infection on the Microbial Composition of Upper Airway.

Authors:  Zhenguo Wang; Xiaojun Hu; Zhonghe Li; Huitao Zhang; Changli Tu; Yiming Wang; Pengfei Pang; Xiaobin Zheng; Yingjian Liang; Hong Shan; Jing Liu
Journal:  Infect Drug Resist       Date:  2020-07-31       Impact factor: 4.003

Review 2.  Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases.

Authors:  Xinquan Li; Qiang Wang; Xiafen Hu; Wanxin Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-03-14       Impact factor: 5.293

Review 3.  Do children's upper respiratory tract infections benefit from probiotics?

Authors:  Susanna Esposito; Donato Rigante; Nicola Principi
Journal:  BMC Infect Dis       Date:  2014-04-10       Impact factor: 3.090

4.  Seasonal variation of respiratory pathogen colonization in asymptomatic health care professionals: A single-center, cross-sectional, 2-season observational study.

Authors:  Ali Hassoun; Matthew D Huff; David Weisman; Khushdeep Chahal; Esmeralda Asis; Don Stalons; Elena Grigorenko; Jessica Green; Leslie L Malone; Scott Clemmons; Stanley Lu
Journal:  Am J Infect Control       Date:  2015-06-04       Impact factor: 2.918

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.